2025 HCPCS Code C7501
Percutaneous breast biopsies using stereotactic guidance, with placement of breast localization device(s) (eg, clip, metallic pellet), when performed, and imaging of the biopsy specimen, when performed, all lesions unilateral and bilateral (for single lesion biopsy, use appropriate code)
TAGS: using lesion lesions localization imaging appropriate bilateral stereotactic metallic biopsy placement unilateral biopsies percutaneous singleShort Description | Perc bx breast lesions stero |
Product Note | 0229 |
HCPCS Action Code | N - No maintenance for this code |
HCPCS Coverage Code | C - Carrier judgment |
HCPCS Code Added Date | January 01, 2023 |
HCPCS Action Effective Date | January 01, 2023 |
HCPCS Pricing Indicator Code | 11 - Price established using national rvu's |
HCPCS Type Of Service Code | 2 - Surgery |
HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
HCPCS Anesthesia Base Unit Quantity | 0 |
HCPCS Coverage Issues Manual Reference Section Number |
Check Similar HCPCS Codes
- C9034 - Injection, dexamethasone 9%
- C9035 - Injection, aristada initio
- C9036 - Injection, patisiran
- C9037 - Injection, risperidone
- C9038 - Inj mogamulizumab-kpkc
- C9039 - Injection, plazomicin
- C9040 - Injection, fremanezumab-vfrm
- C9041 - Inj, coagulation factor xa
- C9042 - Inj., belrapzo 1 mg
- C9043 - Injection, levoleucovorin
- C9044 - Injection, cemiplimab-rwlc
- C9045 - Moxetumomab pasudotox-tdfk
- C9046 - Cocaine hcl nasal (goprelto)
- C9047 - Injection, caplacizumab-yhdp
- C9048 - Dexamethasone ophth insert
- C9049 - Injection, tagraxofusp-erzs
- C9050 - Injection, emapalumab-lzsg
- C9051 - Injection, omadacycline
- C9052 - Injection, ravulizumab-cwv
- C9053 - Inj, crizanlizumab-tmca